We are live on ! Find out more

ECYT

Endocyte, Inc. Common Stock

ECYT

Delisted

ECYT was delisted on the 20th of December, 2018.

82 hedge funds and large institutions have $35.8M invested in Endocyte, Inc. Common Stock in 2017 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 28 increasing their positions, 26 reducing their positions, and 18 closing their positions.

New

Increased

Maintained

Reduced

Closed

726% more call options, than puts

Call options by funds: $289K | Put options by funds: $35K

8% more repeat investments, than reductions

Existing positions increased: 28 | Existing positions reduced: 26

5% less capital invested

Capital invested by funds: $37.8M → $35.8M (-$2.04M)

15% less funds holding

Funds holding: 96 → 82 (-14)

50% less first-time investments, than exits

New positions opened: 9 | Existing positions closed: 18

Holders

Holders Change

-14

Holders Change %

-14.58%

% of All Funds

2.04%

Holding in Top 10

–

Holding in Top 10 Change

–

Holding in Top 10 Change %

–

% of All Funds

–

New

Increased

Reduced

Closed

Calls

$289K

Puts

$35K

Net Calls

+$254K

Net Calls Change

+$133K

Top Buyers

Rank	Fund	Capital Flow
1	BlackRock New York	+$4.63M
2	Vanguard Group Malvern, Pennsylvania	+$332K
3	Renaissance Technologies New York	+$330K
4	AG Algert Global San Francisco, California	+$310K
5	PPA Parametric Portfolio Associates Seattle, Washington	+$138K

Top Sellers

Rank	Fund	Capital Flow
1	HCMT Highland Capital Management (Texas) Dallas, Texas	-$1.18M
2	JP Morgan Chase New York	-$413K
3	ERSOT Employees Retirement System of Texas Austin, Texas	-$347K
4	Millennium Management New York	-$331K
5	Morgan Stanley New York	-$290K

#	Name	Holding	Trade Value	Shares Change	Change in Stake
26	26 California State Teachers Retirement System (CalSTRS) West Sacramento, California	$196K	-$4.16K	-1,800	-2%
27	27 Dimensional Fund Advisors Austin, Texas	$188K	+$81.7K	+35,300	+93%
28	28 New York State Common Retirement Fund Albany, New York	$187K	+$43.4K	+18,752	+35%
29	TA 29 Teachers Advisors New York	$167K	–	–	–
30	SIP 30 Stoneridge Investment Partners Radnor, Pennsylvania	$148K	+$37.9K	+16,399	+40%
31	31 Susquehanna International Group Bala Cynwyd, Pennsylvania	$122K	-$159K	-68,515	-59%
32	32 Stifel Financial St. Louis, Missouri	$112K	+$3.96K	+1,711	+4%
33	33 State Board of Administration of Florida Retirement System Tallahassee, Florida	$111K	–	–	–
34	34 RhumbLine Advisers Boston, Massachusetts	$111K	+$1.28K	+553	+1%
35	ARTA 35 A.R.T. Advisors New York	$103K	+$34.7K	+15,020	+60%
36	MCM 36 Matarin Capital Management New York	$101K	+$90.9K	+39,307	New
37	37 Goldman Sachs New York	$95K	-$107K	-46,421	-56%
38	1SB 38 1ST Source Bank South Bend, Indiana	$84K	–	–	–
39	39 Two Sigma Investments New York	$81K	-$54.1K	-23,369	-42%
40	40 Parallax Volatility Advisers San Francisco, California	$78K	+$69.8K	+30,178	New
41	LCM 41 Leisure Capital Management Costa Mesa, California	$75K	-$1.94K	-839	-3%
42	42 Jacobs Levy Equity Management Florham Park, New Jersey	$74K	-$110K	-47,747	-63%
43	CCM 43 Cribstone Capital Management Augusta, Maine	$66K	–	–	–
44	44 VOYA Investment Management Atlanta, Georgia	$60K	–	–	–
45	AIG 45 American International Group New York	$60K	+$3.6K	+1,558	+7%
46	NCCM 46 Nine Chapters Capital Management Short Hills, New Jersey	$60K	+$54.4K	+23,500	New
47	CG 47 Cutler Group San Francisco, California	$57K	+$1.16K	+500	+2%
48	WS 48 Wedbush Securities Los Angeles, California	$56K	-$7.87K	-3,400	-13%
49	NFA 49 Nationwide Fund Advisors Columbus, Ohio	$54K	-$59.9K	-25,877	-55%
50	50 AllianceBernstein Nashville, Tennessee	$50K	–	–	–

ECYT Hedge Fund Activity: Q1 2017 in Review

82 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in Endocyte, Inc. Common Stock (ECYT) for Q1 2017, worth a combined $35.8M — down 5.4% from $37.8M a quarter earlier.

Sellers outnumbered buyers: 18 funds closed out of ECYT and 9 opened new positions — a net loss of 9 holders — while 26 trimmed existing stakes and 28 added.

The largest buyer was BlackRock, adding an estimated $4.63M. The largest seller was Highland Capital Management (Texas), exiting entirely with an estimated $1.18M sold.

82 institutional investors held Endocyte, Inc. Common Stock (ECYT) as of Q1 2017, down from 96 in Q4 2016.
Funds reported $35.8M of Endocyte, Inc. Common Stock stock for Q1 2017, down 5.4% quarter-over-quarter.
9 funds opened new Endocyte, Inc. Common Stock positions in Q1 2017 and 18 closed out, a net change of -9 holders.
The largest Endocyte, Inc. Common Stock buyer in Q1 2017 was BlackRock, an estimated $4.63M added.
The largest Endocyte, Inc. Common Stock seller in Q1 2017 was Highland Capital Management (Texas), an estimated $1.18M sold.

Based on aggregated 13F filings for Q1 2017.

Endocyte, Inc. Common Stock ECYT